Gene therapy for children with X-linked myotubular myopathy: a plain language summary of publication for the ASPIRO study
What is this summary about? This summary describes the results of a research study (clinical trial) called ASPIRO that was published in the Lancet Neurology in 2023. This study looked at an investigational gene therapy called resamirigene bilparvovec (also known as AT132) as a possible treatment for...
Збережено в:
| Автори: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
SAGE Publishing
2025-09-01
|
| Серія: | Therapeutic Advances in Rare Disease |
| Онлайн доступ: | https://doi.org/10.1177/26330040251362885 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
